Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An International Study to Characterize the Disease Behaviour of Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease During the Peri-Diagnostic Period

NCT03261037 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT03261037
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03261037 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An International Study to Characterize the Disease Behaviour of Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease During the Peri-Diagnostic Period
Lead sponsor
Hoffmann-La Roche
Phase
Not applicable
Overall status
Completed
Start date
December 25, 2017
Completion date
November 27, 2019
Enrollment
178 (actual)
Sites
37

Conditions

As the registry lists them; a condition with its own page is linked.

idiopathic pulmonary fibrosis, interstitial lung disease